Ark Therapeutics

Activities: Research & Development

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  2. CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
  3. ISPE announces 2024 Facility of the Year Awards category winners The awards programme recognises pharmaceutical companies that are the 'best' in the industry for innovation, operations, digitalisation, supply chain and social impact
  4. Tabletability, compactability and compressibility: What’s the difference? To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
  5. Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

Related Content

Research & Development

Ark Therapeutics makes a promotion

David Venables will become ceo on 1 August
Pharmaceutical

New head of business development for Ark

Kassim Kolia will build firm’s manufacturing services business at Finland facility
Research & Development

David Venables joins Ark Therapeutics

As executive director of manufacturing services
Manufacturing

Ark agrees manufacturing deal with Glasgow University

To support development of gene-therapy programme for treating vein graft failure
Manufacturing

Ark and PsiOxus sign manufacturing agreement

To support the development of colorectal cancer treatment
Research & Development

Ark-led consortium wins €5.3m grant

To fund project that combines adenoviral-delivered gene therapeutics and stem cell therapy
Research & Development

Ark wins funding to progress lentiviral technology

Grants awarded by agencies in Finland
Subscribe now